Results 341 to 350 of about 3,264,535 (355)

Monitoring immune-checkpoint blockade: response evaluation and biomarker development

Nature Reviews Clinical Oncology, 2017
Mizuki Nishino, Hiroto Hatabu, F Stephen Hodi   +2 more
exaly  

Protein normal-mode dynamics: trypsin inhibitor, crambin, ribonuclease and lysozyme.

Journal of Molecular Biology, 1985
Michael Levitt, Chris Sander, Peter S. Stern   +2 more
semanticscholar   +1 more source

The evolving landscape of tissue‐agnostic therapies in precision oncology

Ca-A Cancer Journal for Clinicians
Vivek Subbiah, Bettina Ryll, Razelle Kurzrock   +2 more
exaly  

Interplay between β-lactamases and new β-lactamase inhibitors

Nature Reviews Microbiology, 2019
Karen Bush, Patricia A Bradford
exaly  

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

Nature, 2009
Michael A Milhollen, James J Garnsey, Lawrence R Dick   +2 more
exaly  

Spectrophotometric Determination of Trypsin and Trypsin Inhibitors

Analytical Chemistry, 1957
M. B. Rhodes, R. M. Hill, R. E. Feeney
openaire   +1 more source

Crystallographic refinement of the structure of bovine pancreatic trypsin inhibitor at l.5 Å resolution

, 1975
J. Deisenhofer, W. Steigemann
semanticscholar   +1 more source

[Trypsin inhibitors. IV. 2 specific trypsin inhibitors from porcine pancreas].

Hoppe-Seyler's Zeitschrift fur physiologische Chemie, 1970
H, Tschesche, E, Wachter, S, Kupfer, K, Niedermeier   +3 more
openaire   +1 more source

Kunitz Trypsin Inhibitor

2008
openaire   +1 more source

SWITCH TO AROMATASE INHIBITOR BETTER THAN CONTINUING TAMOXIFEN

Ca-A Cancer Journal for Clinicians, 2005
exaly